Published in Hypertension on September 01, 2001
High dietary sodium intake impairs endothelium-dependent dilation in healthy salt-resistant humans. J Hypertens (2013) 1.59
Dietary sodium loading impairs microvascular function independent of blood pressure in humans: role of oxidative stress. J Physiol (2012) 1.05
The growing problem of intradialytic hypertension. Nat Rev Nephrol (2009) 0.93
Estimating the potential health impact and costs of implementing a local policy for food procurement to reduce the consumption of sodium in the county of Los Angeles. Am J Public Health (2011) 0.92
Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 0.84
A mathematical model of long-term renal sympathetic nerve activity inhibition during an increase in sodium intake. Am J Physiol Regul Integr Comp Physiol (2013) 0.78
Relationships between selected gene polymorphisms and blood pressure sensitivity to weight loss in elderly persons with hypertension. Hypertension (2013) 0.77
Signatures of miR-181a on renal transcriptome and blood pressure. Mol Med (2015) 0.77
Low Response of Renin-Angiotensin System to Sodium Intake Intervention in Chinese Hypertensive Patients. Medicine (Baltimore) (2016) 0.75
Sodium and Its Role in Cardiovascular Disease - The Debate Continues. Front Endocrinol (Lausanne) (2016) 0.75
British Hypertension Society guidelines for hypertension management 1999: summary. BMJ (1999) 8.80
A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens (2008) 6.82
Survey of use of anticoagulation in patients with atrial fibrillation. BMJ (1993) 5.71
Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens (2002) 4.93
Double-blind randomised trial of modest salt restriction in older people. Lancet (1997) 3.96
Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev (2004) 3.90
Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J Hum Hypertens (2007) 3.20
Renal artery stenosis masquerading as congestive heart failure. Lancet (1993) 3.10
Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet (1982) 3.07
Sarcoidosis, thyroiditis, and Addison's disease. Lancet (1970) 2.84
Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet (1989) 2.19
Better blood pressure control: how to combine drugs. J Hum Hypertens (2003) 2.19
Salt--more adverse effects. Lancet (1996) 2.17
Is "idiopathic" edema idiopathic? Lancet (1979) 2.11
Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int (1980) 2.01
Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.84
Diuretic-induced oedema. Lancet (1975) 1.84
Moderate potassium supplementation in essential hypertension. Lancet (1982) 1.83
Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J Hypertens (1996) 1.81
Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage. Clin Chim Acta (1978) 1.77
The measurement of angiotensin-converting enzyme in subjects receiving captopril. N Engl J Med (1980) 1.72
Familial Guillain-Barré syndrome. Lancet (1965) 1.71
Fortnightly review: Beneficial effects of potassium. BMJ (2001) 1.59
Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertens (2003) 1.59
Platelet volume is not increased in essential hypertension. J Hum Hypertens (1994) 1.48
Mineralocorticoid deficiency in HIV infection. BMJ (1989) 1.43
Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature (1981) 1.42
Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42
Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens (1991) 1.39
Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet (1985) 1.38
The use of HMG Co-A reductase inhibitors following acute myocardial infarction in hospital practice. Postgrad Med J (1998) 1.37
Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med (1994) 1.37
Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet (1986) 1.32
Sodium is more important than calcium in essential hypertension. Hypertension (1985) 1.26
Structural skin capillary rarefaction in essential hypertension. Hypertension (1999) 1.21
Long term reduction in sodium balance: possible additional mechanism whereby nifedipine lowers blood pressure. BMJ (1990) 1.21
Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin. J Hypertens (1985) 1.21
Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol. Br Med J (Clin Res Ed) (1982) 1.18
Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart (2003) 1.16
Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension (1999) 1.15
Importance of the renin system in determining blood pressure fall with salt restriction in black and white hypertensives. Hypertension (1998) 1.15
Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme. Br Med J (1979) 1.14
Hyperthyroidism and a parathyroid adenoma complicating lithium treatment. Lancet (1977) 1.12
Dietary salt and blood pressure. Lancet (1994) 1.08
Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man. Br J Clin Pharmacol (1976) 1.08
Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens (1993) 1.04
Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study. Br Med J (Clin Res Ed) (1987) 1.04
Maximization of skin capillaries during intravital video-microscopy in essential hypertension: comparison between venous congestion, reactive hyperaemia and core heat load tests. Clin Sci (Lond) (1999) 1.04
Effect of salt intake on renal excretion of water in humans. Hypertension (2001) 1.04
Effect of sodium intake on ability of human plasma to inhibit renal Na+-K+-adenosine triphosphatase in vitro. Lancet (1981) 1.02
Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction? Br Med J (Clin Res Ed) (1985) 1.01
Capillary rarefaction in the forearm skin in essential hypertension. J Hypertens (1995) 1.01
A randomized crossover study to compare the blood pressure response to sodium loading with and without chloride in patients with essential hypertension. J Hypertens (1988) 1.01
A family with autosomal dominant polycystic kidney disease not linked to chromosome 16p13.3. Clin Genet (1993) 1.00
Diuretics and oedema: how to avoid rebound sodium retention. Lancet (1992) 1.00
Contrasting effects of nifedipine, captopril, and propranolol in normotensive and hypertensive subjects. J Cardiovasc Pharmacol (1982) 0.99
Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine. J Cardiovasc Pharmacol (1985) 0.98
Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed) (1985) 0.98
Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. Br Med J (Clin Res Ed) (1981) 0.98
Physiology: cardiac peptides and the control of sodium excretion. Nature (1984) 0.97
Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens (1996) 0.97
Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension. Am J Med (1991) 0.96
Dietary sodium and potassium intake and blood pressure. Lancet (1983) 0.96
Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. J Hum Hypertens (1991) 0.95
Letter: Saralasin bolus test. Lancet (1975) 0.95
Sodium and blood pressure. Curr Opin Cardiol (2002) 0.95
The natriuretic hormone and essential hypertension. Lancet (1982) 0.94
Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. Hypertension (1995) 0.94